化合物Etripamil T15257

Product Introduction
Bioactivity


英文名: Etripamil

描述: Etripamil (MSP-2017) 是一种短效L 型钙通道拮抗剂，可用于治疗阵发性室上性心动过速的研究。它通过抑制房室结细胞中钙慢通道的钙离子流入，显示房室结传导并延长房室结不应期

体外活性: Etripamil通过抑制心房室结细胞中的钙缓慢通道中的钙离子流入，显示心房室结传导并延长心房室结不应期。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: Ethanol : 110 mg/mL (243.05 mM)


关键字: Ca2+ channels | Calcium Channel | Etripamil | MSP2017 | inhibit | Inhibitor | Ca channels | MSP 2017

相关产品: 3-Acetoxy-8(17),13E-labdadien-15-oic acid | NPS-2143 | Catharanthine | Lercanidipine hydrochloride | Manidipine dihydrochloride | RO2959 Hydrochloride | Gallopamil hydrochloride | Strontium ranelate | ω-Conotoxin CnVIIA | Urolithin C

相关库: Ion Channel Inhibitor Library | Drug Repurposing Compound Library | Anti-Hypertension Compound Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Inhibitor Library | Anti-Cancer Clinical Compound Library | Metabolism Compound Library | Bioactive Compound Library

化合物Etripamil T15257信息由TargetMol中国为您提供，如您想了解更多关于化合物Etripamil T15257报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途